Peptide record

TPDB09603

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09603
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP pep-lab Peptipedia ACP740 _ACP240 AntiCP 2.0 SATPdb iACP-DRLF Antifungipept CAFPdb i2APP dbAMP 3.0 ToxinPred 3.0
standard
No
A 20-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FLGGLIKIVPAMICAVTKKC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C97H169N23O22S3
RNDEQHSWY
IK
2105.73
9.80
3
0
11
+3
-1.34
1.400
136.50
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
125
0.06
3
Residue Composition
number
2
A
0
R
0
N
0
D
2
C
0
E
0
Q
2
G
0
H
3
I
2
L
3
K
1
M
1
F
1
P
0
S
1
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 2 H: 0 I: 3 L: 2 K: 3 M: 1 F: 1 P: 1 S: 0 T: 1 W: 0 Y: 0 V: 2
Chemical Descriptors
20 reviewed residue count
C97H169N23O22S3 sequence-only estimate (linear, free termini)
2105.73 sequence-only estimate (linear, free termini)
9.80 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-1.34 sequence-only estimate (linear, free termini)
1.400 sequence-only estimate (linear, free termini)
Evidence Records 15 records
Evidence 1 Activity

Activity

MIC
Antibacterial
4 µg/mL

Target

Staphylococcus aureus or MRSA

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active as the WT against S. aureus or MRSA (MIC 4 ug/ml), P.aeruginosa (MIC 128 ug/ml), E. coli (MIC 32 ug/ml).
Evidence 2 Activity

Activity

MIC
Antibacterial
128 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP DRAMP

Other

active as the WT against S. aureus or MRSA (MIC 4 ug/ml), P.aeruginosa (MIC 128 ug/ml), E. coli (MIC 32 ug/ml).
Evidence 3 Activity

Activity

MIC
Antibacterial
32 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

active as the WT against S. aureus or MRSA (MIC 4 ug/ml), P.aeruginosa (MIC 128 ug/ml), E. coli (MIC 32 ug/ml).
Evidence 4 Activity

Activity

MIC
Antifungal
4 µg/mL

Target

Staphylococcus aureus or MRSA

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
active as the WT against S. aureus or MRSA (MIC 4 ug/ml), P.aeruginosa (MIC 128 ug/ml), E. coli (MIC 32 ug/ml).
Evidence 5 Activity

Activity

MIC
Antifungal
128 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

active as the WT against S. aureus or MRSA (MIC 4 ug/ml), P.aeruginosa (MIC 128 ug/ml), E. coli (MIC 32 ug/ml).
Evidence 6 Activity

Activity

MIC
Antifungal
32 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

active as the WT against S. aureus or MRSA (MIC 4 ug/ml), P.aeruginosa (MIC 128 ug/ml), E. coli (MIC 32 ug/ml).
Evidence 7 Activity

Activity

MIC
Antiparasitic
4 µg/mL

Target

Staphylococcus aureus or MRSA

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
active as the WT against S. aureus or MRSA (MIC 4 ug/ml), P.aeruginosa (MIC 128 ug/ml), E. coli (MIC 32 ug/ml).
Evidence 8 Activity

Activity

MIC
Antiparasitic
128 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP 3.0 DRAMP

Other

active as the WT against S. aureus or MRSA (MIC 4 ug/ml), P.aeruginosa (MIC 128 ug/ml), E. coli (MIC 32 ug/ml).
Evidence 9 Activity

Activity

MIC
Antiparasitic
32 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP

Other

active as the WT against S. aureus or MRSA (MIC 4 ug/ml), P.aeruginosa (MIC 128 ug/ml), E. coli (MIC 32 ug/ml).
Evidence 10 Activity

Activity

MIC
Antiviral
4 µg/mL

Target

Staphylococcus aureus or MRSA

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
active as the WT against S. aureus or MRSA (MIC 4 ug/ml), P.aeruginosa (MIC 128 ug/ml), E. coli (MIC 32 ug/ml).
Evidence 11 Activity

Activity

MIC
Antiviral
128 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP 3.0 DRAMP

Other

active as the WT against S. aureus or MRSA (MIC 4 ug/ml), P.aeruginosa (MIC 128 ug/ml), E. coli (MIC 32 ug/ml).
Evidence 12 Activity

Activity

MIC
Antiviral
32 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP

Other

active as the WT against S. aureus or MRSA (MIC 4 ug/ml), P.aeruginosa (MIC 128 ug/ml), E. coli (MIC 32 ug/ml).
Evidence 13 Activity

Activity

IC50
Toxicity
14.8 µg/mL
Cytotoxic
IC50 | 14.8 | µg/mL | target cell: Monkey COS-7 cells

Target

Monkey COS-7 cells

Source & Reference

NA
DBAASP
Molecular cloning and expression of ranalexin, a bioactive antimicrobial peptide from Rana catesbeiana in Escherichia coli and assessments of its biological activities. | Appl Microbiol Biotechnol | 2013
Evidence 14 Activity

Activity

<15% Hemolysis
Toxicity
250 µg/mL
Hemolytic Cytotoxic
<15% Hemolysis | 250 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae | PLoS One | 2015
Evidence 15 Activity

Activity

Toxicity
Cytotoxic
- | NA | target cell: Human lung normal epithelial cells NL20

Target

Human lung normal epithelial cells NL20

Source & Reference

NA
DBAASP
Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae | PLoS One | 2015